Loading...
PhD Tina Vida Plavec

PhD Tina Vida Plavec
no.: 51651 source: ARIS

researcher – active in research organisation
Research activity

Code Science Field Subfield
4.06.00  Biotechnical sciences  Biotechnology   
1.09.00  Natural sciences and mathematics  Pharmacy   
Bibliography Representative bibliographic units | Personal| COBISS+
source: COBISS
source: SICRIS
Points
365.97
A''
0
A'
148.13
A1/2
291.21
CI10
129
CImax
53
h10
4
A1
1.27
A3
0
Data for the last 5 years (citations for the last 10 years) on December 5, 2023; A3 for period 2017-2021 (update for tender in 2022: YES)
Data for ARIS tenders ( 14.06.2023 – Target research programmes, archive )
Database Linked records Citations Pure citations Average pure citations
WoS 11  141  107  9.73 
Scopus 11  163  129  11.73 
Doctoral dissertations and other final papers Show
Obtaining results now
source: COBISS
Employments
source: ARIS
Type of employment Research org. Research group
Full time employment (50%, RD:50%)  Jožef Stefan Institute  Odsek za biotehnologijo (Slovene) 
Full time employment (70%, RD:20%)  University of Ljubljana, Faculty of Pharmacy  Chair for Pharmaceutical Chemistry 
Research projects Legend
source: ARIS
no. Code Title Period Head No. of publications
1. J7-4418  Nanovlakna za sočasno dostavo koktajlov izbrane mikrobiote in protimikrobnih učinkovin za lokalno zdravljenje vaginalnih infekcij (Slovene)   2022 - 2023  PhD Špela Zupančič  5,178 
2. J7-4420  Selektivno mehansko odstranjevanje bakterijskih biofilmov s konjugiranimi magnetnimi nanodelci (Slovene)   2022 - 2023  PhD Aleš Berlec  3,694 
3. J3-3079  Bactericidal nanoblades: a proof-of-concept approach for bimodal chemo-mechanical eradication of persistent biofilms   2021 - 2023  PhD Stane Pajk  2,334 
4. J4-3088  Intra-biofilm dynamics of Campylobacter with other bacteria: effects on biofilm formation and composition with a view to the design of innovative control strategies   2021 - 2023  PhD Anja Klančnik  3,984 
5. J4-3096  Recombinant probiotics as bio-alternative antimicrobial approach against Clostridioides difficile   2021 - 2023  PhD Borut Štrukelj  2,969 
6. N3-0184  Small protein blockers of IL-23/IL-17 axis as intestinal inflammation inhibitors secreted by probiotic bacteria   2021 - 2023  PhD Aleš Berlec  1,344 
7. J3-2517  Development of innate immune receptor-targeting chimeras as custom-tailored vaccine adjuvants   2022 - 2023  PhD Žiga Jakopin  1,984 
8. J4-1771  NEW ANTIMICROBIAL STRATEGIES IN PREVENTION OF BIOFILM FORMATION BY USING LECTINS THAT INHIBIT BACTERIAL ADHESION   2019 - 2022  PhD Jerica Sabotič  1,946 
9. J4-8227  Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy   2018 - 2020  PhD Janko Kos  4,466 
10. J3-8201  Nuclear transport defects in neurodegenerative diseases   2018 - 2020  PhD Boris Rogelj  2,263 
ARIS research and infrastructure programmes Legend
source: ARIS
no. Code Title Period Head No. of publications
1. P4-0127  Pharmaceutical biotechnology: Science for health   2019 - 2023  PhD Janko Kos  4,985 
2. P4-0127  Pharmaceutical biotechnology: Science for Health   2018  PhD Janko Kos  4,884 
We were not given permission by the researcher to publish data.
Views history
Favourite